ES347203A1 - Procedimiento para preparar composiciones de materia actva farmaceutica. - Google Patents

Procedimiento para preparar composiciones de materia actva farmaceutica.

Info

Publication number
ES347203A1
ES347203A1 ES347203A ES347203A ES347203A1 ES 347203 A1 ES347203 A1 ES 347203A1 ES 347203 A ES347203 A ES 347203A ES 347203 A ES347203 A ES 347203A ES 347203 A1 ES347203 A1 ES 347203A1
Authority
ES
Spain
Prior art keywords
compositions
pharmaceutically acceptable
tablets
weight
mental disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES347203A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JR Geigy AG filed Critical JR Geigy AG
Publication of ES347203A1 publication Critical patent/ES347203A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES347203A 1966-11-16 1967-11-15 Procedimiento para preparar composiciones de materia actva farmaceutica. Expired ES347203A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59467366A 1966-11-16 1966-11-16
US67196467A 1967-10-02 1967-10-02

Publications (1)

Publication Number Publication Date
ES347203A1 true ES347203A1 (es) 1969-05-16

Family

ID=27082048

Family Applications (1)

Application Number Title Priority Date Filing Date
ES347203A Expired ES347203A1 (es) 1966-11-16 1967-11-15 Procedimiento para preparar composiciones de materia actva farmaceutica.

Country Status (7)

Country Link
BE (1) BE706610A (de)
DE (1) DE1617508C3 (de)
ES (1) ES347203A1 (de)
FR (1) FR7065M (de)
GB (1) GB1184110A (de)
IL (1) IL28951A (de)
NL (1) NL6715531A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
DE10310196A1 (de) * 2003-03-06 2004-09-23 Rina-Netzwerk Rna Technologien Gmbh Verwendung eines trizyklischen Antidepressivums zur Förderung der Endozytose

Also Published As

Publication number Publication date
GB1184110A (en) 1970-03-11
DE1617508A1 (de) 1972-03-23
BE706610A (de) 1968-05-16
DE1617508B2 (de) 1973-02-01
IL28951A (en) 1971-10-20
DE1617508C3 (de) 1974-04-11
FR7065M (de) 1969-06-23
NL6715531A (de) 1968-05-17

Similar Documents

Publication Publication Date Title
US2890984A (en) Pharmaceutical composition containing 2-(1, 2, 3, 4-tetrahydro-1-naphthyl)imidazo-line
GB1192812A (en) 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
Kellner et al. The short-term antianxiety effects of propranolol HCL.
Sovner et al. The effect of benztropine mesylate in the rabbit syndrome and tardive dyskinesia.
US3557292A (en) Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
ES347203A1 (es) Procedimiento para preparar composiciones de materia actva farmaceutica.
US3312593A (en) Anti-inflammatory compositions of aspirin and niacin
ES354055A1 (es) Un procedimiento para la preparacion de nuevas anilidas de acido quinuclidino-2-carboxilico y quinuclidino-3-carboxili-co.
GB1210968A (en) Improvements in or relating to the treatment of gastric ailments
Korol et al. Conditioned physiological adaptation to anticholinergic drugs
Klotz Long-term safety of Nefopam hydrochloride (Acupan), a new analgesic formulation.
Baumgartner et al. An observer-blind crossover study to compare the efficacies of flurbiprofen, indomethacin and naproxen given orally and rectally in the relief of night pain and morning stiffness due to rheumatoid arthritis
GB1327469A (en) Pharmaceutical compositions for inhibiting indoleamine n-methyl transferase
GB1300486A (en) Compositions for the treatment of respiratory ailments in man
Meshel et al. Double-blind study of tybamate in psychotic patients.
SCHUBERT et al. Are divided doses of tricyclic antidepressants necessary?
GB1254893A (en) Therapeutic composition
GB1050396A (de)
Doyle Imipramine pamoate in depression.
Tallarida et al. Clinoril®(Merck Sharp & Dohme) Sulindac
GB1207745A (en) A tranquillizer-containing composition
GB1176049A (en) N-Substituted Noratropinium Salts
GB1167688A (en) Dealkylation of Cyclic N-alkyl Derivatives
GB1125924A (en) Organic bismuth derivative